Neoplasma
(ISSN: 0028-2685)
January 1, 2008 - Volume 55, Issue 2
Tumor markers in staging and prognosis of colorectal carcinoma. Levy M; Visokai V; Lipska L, et al. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases. Naidu R; Yip CH; Taib NA Parallel-opposed fields versus four fields, and two- versus three-dimensional radiotherapy planning in thin patients with gynecological malignancies. Bednaruk-M Ynski E; Senkus-Konefka E; Szewczyk P, et al. alpha-Lipoic acid - the potential for use in cancer therapy. Novotny L; Rauko P; Cojocel C Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma. Stukavec J; Horak L; Duchac V, et al. An increased level of the Concanavalin A - positive IgG in the serum of patients with gastric cancer as evaluated by a lectin enzyme-linked immunosorbent assay (LELISA). Klaamas K; Kodar K; Kurtenkov O Prognostic impact of bone involvement in Hodgkin lymphoma. Feltl D; Markova J; Mocikova H, et al. Long-Term BRCA1 Down-Regulation by Small Hairpin RNAs Targeting the 3' Untranslated Region. Vondruskova E; Malik R; Sevcik J, et al. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome. Papadopoulou E; Tripsianis G; Anagnostopoulos K, et al. Antitumor and biological effects of black pine (pinus nigra) pollen nuclease. Lipovova P; Podzimek T; Orctova L, et al.
